Effect of telehealth on quality of life and psychological outcomes over 12 months (Whole Systems Demonstrator telehealth questionnaire study): Nested study of patient reported outcomes in a pragmatic, cluster randomised controlled trial

BMJ (Online)

Volumn 346, Issue 7897, 2013, Pages

  Martin Cartwright, ^a   Hirani, Shashivadan P ^a   Rixon, Lorna ^a   Beynon, Michelle ^a   Doll, Helen ^b   Bower, Peter ^f   Bardsley, Martin ^c   Steventon, Adam ^c   Knapp, Martin ^d   Henderson, Catherine ^d   Rogers, Anne ^e   Sanders, Caroline ^f   Fitzpatrick, Ray ^g   Barlow, James ^h   Newman, Stanton P ^a  

^a CITY UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^c The Nuffield Trust   (United Kingdom)

^d LONDON SCHOOL OF ECONOMICS   (United Kingdom)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONTROLLED STUDY; DEPRESSION; DIABETES MELLITUS; GENERAL PRACTICE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STATE TRAIT ANXIETY INVENTORY; TELEHEALTH; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; ANXIETY; CASE-CONTROL STUDIES; CLUSTER ANALYSIS; DEPRESSION; DIABETES MELLITUS; ENGLAND; FEMALE; GENERAL PRACTICE; HEALTH STATUS; HEART FAILURE; HOME CARE SERVICES; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; TELEMEDICINE;

EID: 84874641201     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f653     Document Type: Article

References (89)

1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009;374:1196-208.
2. Office for National Statistics. The interactive population pyramid. 2011. www.neighbourhood.statistics.gov.uk/HTMLDocs/dvc1/UKPyramid.html.
3. Spillman BC, Lubitz J. The effect of longevity on spending for acute and long-term care. N Engl J Med 2000;342:1409-15. (Pubitemid 30262399)
4. Robine J-M, Romieu I, Michel J. Trends in health expectancies. In: Robine J-M, Jagger C, Mathers C, Crimmins EM, Suzman R, eds. Determining health expectancies. John Wiley and Sons, 2003:75-104.
5. Doblhammer G, Kytir J. Compression or expansion of morbidity? Trends in healthy-life expectancy in the elderly Austrian population between 1978 and 1998. Soc Sci Med 2001;52:385-91.
6. Rice DP. Economic implications of increased longevity in the United States. Annu Rev Public Health 2004;25:457-73. (Pubitemid 38543627)
7. Department of Health. Our health, our care, our say: A new direction for community services. 2006. www.official-documents.gov.uk/document/cm67/6737/6737. pdf.
8. McLean S, Protti D, Sheikh A. Telehealthcare for long term conditions. BMJ 2011;342:d120.
9. Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, et al. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health 2007;13:573-90.
10. Ramaekers BLT, Janssen-Boyne JJ, Gorgels APM, Vrijhoef HJM. Adherence among telemonitored patients with heart failure to pharmacological and nonpharmacological recommendations. Telemed J E Health 2009;15:517-24.
11. Antonicelli R, Testarmata P, Spazzafumo L, Gagliardi C, Bilo G, Valentini M, et al. Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare 2008;14:300-5.
12. Seibert PS, Whitmore TA, Patterson C, Parker PD, Otto C, Basom J, et al. Telemedicine faciliatates CHF home health care for those with systolic dysfunction. Int J Telemed Appl 2008, doi:10.1155/2008/235031.
13. US Food and Drug Administration. Draft guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims. 2009. www.fda.gov/downloads/Drugs/Guidances/UCM193282.pdf.
14. European Medicines Agency. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005. www.emea.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2009/09/WC500003637.pdf.
15. Department of Health. Guidance on the routine collection of patient reported outcome measures (PROMs). 2009. www.dh.gov.uk/en/ Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH-092647.
16. Dawson J, Doll H, Fitzpatrick R, Jenkinson C, Carr AJ. The routine use of patient reported outcome measures in healthcare settings. BMJ 2010;340:c186.
17. Greenhalgh J, Long AF, Flynn R. The use of patient reported outcome measures in routine clinical practice: lack of impact or lack of theory? Soc Sci Med 2005;60:833-43. (Pubitemid 39574779)
18. Bower P, Cartwright M, Hirani S, Barlow J, Hendy J, Knapp M, et al. A comprehensive evaluation of the impact of telemonitoring in patients with long-term conditions and social care needs: protocol for the Whole Systems Demonstrator cluster randomised trial. BMC Health Serv Res 2011;11:184.
19. Glasgow RE, Ruggiero L, Eakin EG, Dryfoos J, Chobanian L. Quality of life and associated characteristics in a large national sample of adults with diabetes. Diabetes Care 1997;20:562'7. (Pubitemid 27143416)
20. Lloyd CE, Dyer PH, Barnett AH. Prevalence of symptoms of depression and anxiety in a diabetes clinic population. Diabetic Med 2000;17:198-202. (Pubitemid 30212291)
21. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care 1997;20:585-90.
22. Ferrer M, Alonso J, Morera J, Marrades RM, Khalaf A, Aguar MC, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med 1997;127:1072'9.
23. Mikkelsen RL, Middelboe T, Pisinger C, Stage KB. Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry 2004;58:65-70. (Pubitemid 38351199)
24. Putman-Casdorph H, McCrone S. Chronic obstructive pulmonary disease, anxiety, and depression: state of the science. Heart Lung 2009;38:34-47.
25. Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure -a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006;48:1527-37. (Pubitemid 44528168)
26. Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail 2005;11:455-63.
27. Heo S, Moser DK, Lennie TA, Zarnbroski CH, Chung ML. A comparison of health-related quality of life between older adults with heart failure and healthy older adults. Heart Lung 2007;36:16-24.
28. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes -impact of depression symptoms on adherence, function, costs. Arch Intern Med 2000;160:3278-85.
29. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851''8. (Pubitemid 47362344)
30. Yohannes AM, Willgoss TG, Baldwin RC, Connolly MJ. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry 2010;25:1209-21.
31. Maurer J, Rebbapragada V, Borson S, Goldstein R, Kunik ME, Yohannes AM, et al. Anxiety and depression in COPD current understanding, unanswered questions, and research needs. Chest 2008;134:43-56S.
32. Rodriguez-Artalejo F, Guallar-Castillon P, Pascual CR, Otero CM, Montes AO, Garcia AN, et al. Health-related quality of life as a predictor of hospital readmission and death among patients with heart failure. Arch Intern Med 2005;165:1274-9.
33. Martinez A, Everss E, Luis Rojo-Alvarez J, Pascual Figal D, Garcia-Alberola A. A systematic review of the literature on home monitoring for patients with heart failure. J Telemed Telecare 2006;12:234-41.
34. Clark RA, Inglis SC, McAlister FA, Cleland JGF, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007;334:942'5. (Pubitemid 46808391)
35. Maric B, Kaan A, Ignaszewski A, Lear SA. A systematic review of telemonitoring technologies in heart failure. Eur J Heart Fail 2009;11:506-17.
36. Inglis SC, Clark RA, McAlister FA, Ball J, Lewinter C, Cullington D, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010:CD007228.
37. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, et al. Home telemonitoring for congestive heart failure: a systematic review and meta-analysis. J Telemed Telecare 2010;16:68-76.
38. Schmidt S, Schuchert A, Krieg T, Oeff M. Home telemonitoring in patients with chronic heart failure: a chance to improve patient care? Dtsch Arztebl Int 2010;107:131''8.
39. Clarke M, Shah A, Sharma U. Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis. J Telemed Telecare 2011;17:7-14.
40. Anker SD, Koehler F, Abraham WT. Telemedicine and remote management of patients with heart failure. Lancet 2011;378:731''9.
41. Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Bohm M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation 2011;123:1873-80.
42. Bolton CE, Waters CS, Peirce S, Elwyn G. Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract 2011;17:1216-22.
43. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K, et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare 2010;16:120-7.
44. Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab 2009;11:913-30.
45. Maljanian R, Grey N, Staff I, Conroy L. Intensive telephone follow-up to a hospital-based disease management model for patients with diabetes mellitus. Dis Manag 2005;8:15-25. (Pubitemid 40316210)
46. Piette JD, Weinberger M, McPhee SJ. The effect of automated calls with telephone nurse follow-up on patient-centered outcomes of diabetes care: a randomized, controlled trial. Med Care 2000;38:218-30.
47. Whitlock WL, Brown A, Moore K, Pavliscsak H, Dingbaum A, Lacefield D, et al. Telemedicine improved diabetic management. Mil Med 2000;165:579-84. (Pubitemid 30647282)
48. Jansa M, Vidal M, Viaplana J, Levy I, Conget I, Gomis R, et al. Telecare in a structured therapeutic education programme addressed to patients with type 1 diabetes and poor metabolic control. Diabetes Res Clin Pract 2006;74:26-32. (Pubitemid 44810197)
49. Chumbler NR, Neugaard B, Kobb R, Ryan P, Qin HJ, Joo YS. Evaluation of a care coordination/home-telehealth program for veterans with diabetes: health services utilization and health-related quality of life. Eval Health Prof 2005;28:464-78.
50. Rogers A, Kirk S, Gately C, May CR, Finch T. Established users and the making of telecare work in long term condition management: implications for health policy. Soc Sci Med 2011;72:1077-84.
51. Ekeland AG, Bowes A, Flottorp S. Effectiveness of telemedicine: a systematic review of reviews. Int J Med Inform 2010;79:736-71.
52. Barlow J, Singh D, Bayer S, Curry R. A systematic review of the benefits of home telecare for frail elderly people and those with long-term conditions. J Telemed Telecare 2007;13:172'9.
53. Bensink M, Hailey D, Wootton R. A systematic review of successes and failures in home telehealth. Part 2: final quality rating results. J Telemed Telecare 2007;13:10-4.
54. Chaudhry SI, Mattera JA, Krumholz HM. Telemonitoring in patients with heart failure: authors' reply. N Engl J Med 2011;364:1078-80.
55. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin ZQ, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010;363:2301''9.
56. Bowling A, Farquhar M, Browne P. Life satisfaction and associations with social network and support variables in 3 samples of elderly people. Int J Geriatr Psychiatry 1991;6:549-66.
57. Klimidis S, Minas IH, Yamamoto K. Impact of illness scale: reliability, validity, and cross-cultural utility. Compr Psychiatry 2001;42:416-23. (Pubitemid 32884850)
58. Ware JE Jr., Kosinski M, Turner-Bowker DM, Gandek B. User's manual for the SF-12v2 health survey with a supplement documenting SF-12 health survey. QualityMetric, 2002.
59. Mackintosh A, Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures (PROMs) for heart failure. University of Oxford, 2009. http://phi.uhce.ox.ac.uk/pdf/PROMs-Oxford-HeartFailure-17092010. pdf.
60. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-43. (Pubitemid 32675374)
61. Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures (PROMs) for diabetes. University of Oxford, 2009. http://phi.uhce.ox. ac.uk/pdf/Diabetes-2009FINAL.pdf.
62. Davies N, Gibbons E, Fitzpatrick R. A structured review of patient-reported outcome measures (PROMs) for chronic obstructive pulmonary disease (COPD). University of Oxford, 2009. http://phi.uhce.ox.ac.uk/pdf/ COPD2009-FINAL.pdf.
63. Marteau TM, Bekker H. The development of a 6-item short-form of the state scale of the Spielberger state trait anxiety inventory (STAI). Br J Clin Psychol 1992;31:301''6.
64. Perpina-Galvan J, Richart-Martinez M, Jose Cabanero-Martinez M. Reliability and validity of a short version of the STAI anxiety measurement scale in respiratory patients. Arch Bronconeumol 2011;47:184-9.
65. Eborall HC, Griffin SJ, Prevost AT, Kinmonth A-L, French DP, Sutton S. Psychological impact of screening for type 2 diabetes: controlled trial and comparative study embedded in the ADDITION (Cambridge) randomised controlled trial. BMJ 2007;335:486-9.
66. Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short-form of the CES-D. Am J Prev Med 1994;10:77-84. (Pubitemid 24144960)
67. Boey KW. Cross-validation of a short form of the CES-D in Chinese elderly. Int J Geriatr Psychiatry 1999;14:608-17. (Pubitemid 29403279)
68. van Manen JG, Bindels PJE, Dekker FW, Ijzermans CJ, van der Zee JS, Schade E. Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax 2002;57:412'6. (Pubitemid 34494151)
69. Lesman-Leegte I, Jaarsma T, Sanderman R, Linssen G, van Veldhuisen DJ. Depressive symptoms are prominent among elderly hospitalised heart failure patients. Eur J Heart Fail 2006;8:634-40.
70. Mancuso CA, Westermann H, Choi TN, Wenderoth S, Briggs WM, Charlson ME. Psychological and somatic symptoms in screening for depression in asthma patients. J Asthma 2008;45:221''5. (Pubitemid 351549804)
71. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.Lawrence Erlbaum Associates, 1988.
72. Office of National Statistics. Ethnic group statistics: a guide for the collection and classification of ethnicity data. Her Majesty's Stationery Office, 2003:39.
73. Department of Health. Indices of deprivation. 2007. http://webarchive. nationalarchives. gov.uk/+/http:/www.communities.gov.uk/communities/ neighbourhoodrenewal/deprivation/deprivation07/.
74. Eldridge SM, Ashby D, Kerry S. Sample size for cluster randomized trials: effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006;35:1292'300. (Pubitemid 44605554)
75. Allison PD. Missing data. Sage Publications, 2001.
76. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. Wiley-Interscience, 2002.
77. Schafer JL, Olsen MK. Multiple imputation for multivariate missing-data problems: a data analyst's perspective. Multivariate Behav Res 1998;33:545-71. (Pubitemid 128337068)
78. Schafer JL. NORM: multiple imputation of incomplete multivariate data under a normal model (version 2.03). Pennsylvania State University, 1999.
79. Higgins JPT, Deeks JJ, Altman DG. Special topics in statistics: intention-to-treat issues In: Higgins JPT, Green S, eds. Cochrane handbook for systematic reviews of interventions (version 5.1.0). Cochrane Collaboration, 2011.
80. Heritier SR, Gebski VJ, Keech AC. Inclusion of patients in clinical trial analysis: the intention-to-treat principle. Med J Aus 2003;179:438-40. (Pubitemid 37328013)
81. Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ 2012;344:e3874.
82. Henderson C, Knapp M, Fernández J, Beecham J, Hirani S, Cartwright M, et al. Cost-effectiveness of telehealth in patients with long-term conditions: the Whole Systems Demonstrator cluster randomised trial. BMJ [forthcoming].
83. Regan DT. Effects of a favor and liking on compliance. J Exp Soc Psychol 1971;7:627-39.
84. Engstrom CP, Persson LO, Larsson S, Sullivan M. Health-related quality of life in COPD: why both disease-specific and generic measures should be used. Eur Respir J 2001;18:69-76. (Pubitemid 32717433)
85. Katsura H, Yamada K, Kida K. Both generic and disease specific health-related quality of life are deteriorated in patients with underweight COPD. Respir Med 2005;99:624-30. (Pubitemid 40468511)
86. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes 2011;9:26.
87. Bartoli L, Zanaboni P, Masella C, Ursini N. Systematic review of telemedicine services for patients affected by chronic obstructive pulmonary disease (COPD). Telemed J E Health 2009;15:877-83.
88. Jenkinson C, Layte R, Jenkinson D, Lawrence K, Petersen S, Paice C, et al. A shorter form health survey: Can the SF-12 replicate results from the SF-36 in longitudinal studies? J Public Health Med 1997;19:179-86.
89. Sanders C, Rogers A, Bowen R, Bower P, Hirani S, Cartwright M, et al. Exploring barriers to participation and adoption of telehealth and telecare within the Whole System Demonstrator trial: a qualitative study. BMC Health Serv Res 2012;12.